Panaxadiol saponin ameliorates ferroptosis in iron-overload aplastic anemia mice and Meg-01 cells by activating Nrf2/HO-1 and PI3K/AKT/mTOR signaling pathway.
暂无分享,去创建一个
Ruijun Gao | Bolin Wang | Fenglin Shen | Zhengwei Tan | Aĭzimov Mi | Xiao-ling Yu | Yanna Zhao | Wenbin Liu | Yuechao Zhao | Jin Lan
[1] K. Tao,et al. Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation , 2022, Frontiers in Pharmacology.
[2] Chen Fu,et al. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. , 2022, Journal of ethnopharmacology.
[3] Wei Wei,et al. Ginsenoside Rg1 can restore hematopoietic function by inhibiting Bax translocation-mediated mitochondrial apoptosis in aplastic anemia , 2021, Scientific Reports.
[4] H. Leitch,et al. Iron Overload-Induced Oxidative Stress in Myelodysplastic Syndromes and its Cellular Sequelae. , 2021, Critical reviews in oncology/hematology.
[5] Junjie Chen,et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation , 2021, Nature Communications.
[6] M. Conrad,et al. The Metabolic Underpinnings of Ferroptosis. , 2020, Cell metabolism.
[7] X. Cui,et al. Angelica sinensis polysaccharide prevents mitochondrial apoptosis by regulating the Treg/Th17 ratio in aplastic anemia , 2020, BMC Complementary Medicine and Therapies.
[8] J. Ajani,et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression , 2020, Cell Research.
[9] B. Chong,et al. Panaxdiol Saponins Component Promotes Hematopoiesis and Modulates T Lymphocyte Dysregulation in Aplastic Anemia Model Mice , 2019, Chinese Journal of Integrative Medicine.
[10] Hong Liu,et al. Pathogenesis of aplastic anemia , 2019, Hematology.
[11] Dijiong Wu,et al. The Progress of Traditional Chinese Medicine in the Treatment of Aplastic Anemia , 2018, Journal of translational internal medicine.
[12] R. Latagliata,et al. Iron toxicity - Its effect on the bone marrow. , 2018, Blood reviews.
[13] Wenbin Liu,et al. Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload , 2018, Drug design, development and therapy.
[14] Wenbin Liu,et al. A composite mouse model of aplastic anemia complicated with iron overload , 2017, Experimental and therapeutic medicine.
[15] A. Dasgupta,et al. Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients , 2017, European journal of haematology.
[16] P. Northcott,et al. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Yiying Zhao,et al. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma , 2017, Journal of cellular and molecular medicine.
[18] A. Levis,et al. Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study , 2017, Leukemia & lymphoma.
[19] P. Ponikowski,et al. Both iron excess and iron depletion impair viability of rat H9C2 cardiomyocytes and L6G8C5 myocytes. , 2016, Kardiologia polska.
[20] Donghai Huang,et al. Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing , 2016, BMC Cancer.
[21] Yue-min Kuang,et al. Clinical study of Pai-Neng-Da capsule (派能达胶囊) in the treatment of chronic aplastic anemia , 2016, Chinese Journal of Integrative Medicine.
[22] Hong Chang,et al. 地拉罗司对伴有铁过载的再生障碍性贫血患者的祛铁疗效及安全性——一项单臂、多中心、前瞻性临床研究 , 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.
[23] E. Katsanis,et al. The complex pathophysiology of acquired aplastic anaemia , 2015, Clinical and experimental immunology.
[24] V. Beneš,et al. Lymphocyte Gene Expression Signatures from Patients and Mouse Models of Hereditary Hemochromatosis Reveal a Function of HFE as a Negative Regulator of CD8+ T-Lymphocyte Activation and Differentiation In Vivo , 2015, PloS one.
[25] C. Krawczyk,et al. Iron Prevents the Development of Experimental Cerebral Malaria by Attenuating CXCR3-Mediated T Cell Chemotaxis , 2015, PloS one.
[26] C. Schürch,et al. Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. , 2014, Cell stem cell.
[27] N. Young,et al. Current concepts in the pathophysiology and treatment of aplastic anemia. , 2013, Hematology. American Society of Hematology. Education Program.
[28] Di Wu,et al. Bone marrow angiogenesis in patients presenting with differential Chinese medicine syndrome: Correlation with the clinico-pathological features of aplastic anemia , 2013, Chinese Journal of Integrative Medicine.
[29] J. Werner,et al. Reactive Oxygen Species in the Immune System , 2013, International reviews of immunology.
[30] E. Weinberg,et al. Iron availability and infection. , 2009, Biochimica et biophysica acta.
[31] M. Tomonaga,et al. Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes , 2008, International journal of hematology.
[32] J. Karnon,et al. Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom* , 2008, Current medical research and opinion.
[33] Hung-Ming Wang,et al. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15 , 2007, Molecular Cancer Therapeutics.
[34] Shi-hui Li,et al. [Clinical efficacy and T-lymphocyte subset, serum interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin-2(IL-2) levels on treatment of chronic aplastic anemia patients by shenfu injection combined with stanozol and cyclosporin A]. , 2005, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[35] Zaccheaus Awortu. Jeremiah. [Idiopathic thrombocytopenic purpura]. , 1964, Chirurgia e patologia sperimentale.
[36] A. Azarkeivan,et al. Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior , 2017, Caspian journal of internal medicine.
[37] Xin Sun,et al. Effects of panaxadiol saponins component as a new Chinese patent medicine on proliferation, differentiation and corresponding gene expression profile of megakaryocytes , 2015, Chinese Journal of Integrative Medicine.